Intellipharmaceutics International Inc. - 20-F filing on 2022-04-01

Financial Instruments (Tables)

12 Months Ended

Nov. 30, 2021

Financial Instruments (Tables)

Schedule of fair value measurements, nonrecurring

		November 30, 2021								November 30, 2020
		Carrying				Fair				Carrying				Fair
		amount				value				amount				value
			$				$				$				$
Financial Liabilities
Convertible debentures⁽ⁱ⁾			1,751,483				1,783,882				1,791,791				1,784,646
Promissory notes payable⁽ⁱ⁾			165,878				165,878				163,758				163,758

Schedule of past due financing receivables

		November 30,				November 30,
		2021				2020
			$				$
Accounts receivable			-				66,384
Other receivable			-				500,000
Less allowance for doubtful accounts			-				-
Total trade and other receivables, net			-				566,384

Not past due			-				566,384
Past due for more than 31 days but no more than 120 days			-				-
Past due for more than 120 days			-				-
Total trade and other receivables, gross			-				566,384

Contractual obligation, fiscal year maturity schedule

		Less than				3 to 6				6 to 9				9 months				Greater than
		3 months				months				months				to 1 year				1 year				Total
			$				$				$				$				$				$
Accounts payable			3,779,550				-				-				-				-				3,779,550
Accrued liabilities			2,272,610				-				-				-				-				2,272,610
Employee costs payable			2,263,944				-				-				-				-				2,263,944
Convertible debentures (Note 7)			1,800,000				-				-				-				-				1,800,000
Promissory notes payable (Note 7)			165,878				-				-				-				-				165,878
Total contractual obligations			10,281,982				-				-				-				-				10,281,982